FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
December 12, 2022 https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-adagrasib-kras-g12c-muta...
FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
Cancer drugs are closing in on some of the deadliest mutations
SPARK – A STUDY FOR PATIENTS WITH KRAS DRUG RESISTANCE
KRAS Kickers Give Cancer the Boot!
LCRF and KRAS Kickers Announce Partnership
Kristi C.
Deborah C.
Brenda J.
Hug from Brenda
Need a hug?
SPARK, studying pathways of resistance in KRAS-driven cancers